Page 33 - Coronavirus Vaccine

India-made cervical cancer vaccine Ceravac to cost Rs 200-400 per dose

Serum India's product made in collaboration with state-run biotechnology department, expected to bring down prices

Data story: India logs 7,946 new Covid cases; 37 deaths in 24 hrs

India has added 57,419 cases in the past 7 days

Germany's BioNTech gains emergency US approval for Omicron booster

The US FDA granted emergency use authorisation for a 30-microgram booster dose of the Pfizer-BioNTech Covid-19 vaccine, bivalent and Omicron BA.4/BA.5, for individuals aged 12 years and above

Goldman Sachs, Morgan Stanley order staff to return to office full-time

Goldman will let employees outside New York enter offices regardless of vaccination status, with no requirement to participate in regular testing or wear face coverings

Covid booster jabs see 10% dip from last week despite govt push

Just five of 36 states/UTs have covered at least a third of the adult population with a booster dose

News updates: AAP MLAs to meet CBI chief, seek probe into 'Operation Lotus'

From India's GDP data for the April-June quarter to Covid-19 updates, catch all the latest news here

Data story: India records 9,808 new Covid cases; death toll at 527,874

India has added 60,198 cases in the past 7 days

IISc's SARS-CoV-2 virus-like particle may lead to new Covid-19 vaccine

Scientists at the Indian Institute of Science (IISc) Bangalore have developed and tested a novel SARS-CoV-2 virus-like particle that can potentially be developed into a COVID-19 vaccine candidate. To study the SARS-CoV-2 virus, the researchers need to isolate the virus from the samples, create multiple copies of it, and analyse its transmissibility and efficiency at entering living cells. However, working with such a highly infectious virus is dangerous and requires a Bio Safety Level-3 (BSL-3) lab, only a handful of which across the country are equipped to handle such viruses. To address this problem, the team developed and tested a novel virus-like particle (VLP) -- a non-infectious nanoscale molecule that resembles and behaves like the SARS-CoV-2 virus but does not contain its native genetic material. Such VLPs can not only be used to safely study the effect of mutations that may arise in SARS-CoV-2, but can also potentially be developed into a vaccine candidate that can trigger

Covid: 'Only 12% of people in 18-59 age group have taken precaution dose'

Around 12 per cent of the eligible 77 crore population in the age group of 18-59 years have taken the precaution dose of COVID-19 vaccine so far, officials said on Tuesday. Besides, 35 per cent of the 16.80 crore population aged 60 years and above, healthcare and frontline workers have been administered the precaution dose, officials said. A total of 15.66 crore precaution doses have been given till now with 10.39 crore doses being administered since July 15 till now after the 'COVID Vaccination Amrit Mahotsava' was launched, official sources said. The precaution dose coverage among the 64,89,99,721 eligible population between 18-59 years was 8 per cent till July 14. Under the campaign which was launched on July 15, 9,28,598 special vaccination camps have been organised so far by all the states and UTs. This includes camps at railway stations (4,259), bus stations (9,183), airports (370), schools and colleges (1,16,675), on the way to religious places (3,522) and camps at other pl

Covishield usage highest as precaution dose for Covid, says report

The usage of Covishield has been the highest as the precaution dose for COVID-19 as compared to other vaccines, said Union Health Ministry sources

RIL 45th AGM Live: Ambani announces Giga factory for power electronics

From Reliance Industries 45th Annual General Meeting to Covid updates, catch all the latest news here

US likely to authorise updated Covid booster shots for new Omicron variants

The US Food and Drug Administration is expected to approve new ovid-19 booster shots for newer Omicron strains this week, making them accessible to people in the country

Data story: India logs 7,591 new Covid cases; death toll at 527,799

India has added 66,763 cases in the past 7 days

Data story: India logs 9,436 new cases, 157 deaths as states clear backlog

India has added 68,703 cases in the past 7 days

US donates nine million pediatric, Covid-19 vaccine doses to Pakistan

In addition to those Pfizer and Moderna vaccines, the United States also recently donated four mobile testing laboratories, worth $4.6 million, to Pakistan's National Institute of Health through USAID

Over 2.2 mn precautionary Covid jabs being administered per day: Health min

While the daily average Covid vaccination doses cross 2.8 million mark, over 880,000 special vaccination camps have been organised in the country

Moderna sues Pfizer, BioNTech over patents behind Covid-19 vaccine

COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna's technology in order to make their own vaccine. Moderna said on Friday that Pfizer and BioNTech's vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax. The company filed patent infringement lawsuits in both US federal court and a German court. A Pfizer spokeswoman declined to comment, saying the company had not been served with a copy of the litigation. Moderna and Pfizer's two-shot vaccines both use mRNA technology to help patients fight the coronavirus. The mRNA vaccines work by injecting a genetic code for the spike protein that coats the surface of the coronavirus. That code, the mRNA, is encased in a little ball of fat, and instructs the body's cells to make some harmless spike copies that train the immune system to recognise the real virus. Moderna CEO Stephane Ban

BioNTech all set to supply new Covid jab 'very soon' to neutralise Omicron

German biotechnology company BioNTech is planning to start distributing, from early next month, a new Covid-19 vaccine that has been developed to neutralise two Omicron variants

Data story: India records 10,725 new Covid cases, active tally at 94,047

India has added 80,056 cases in the past 7 days

Data story: India records 10,649 new Covid cases, death toll at 527,452

India has so far administered 2,105,883,682 vaccine doses